CM8019s RSV Treatment
RSV TREATMENT STUDY REGISTER YOUR INTEREST NOW
RECRUITING IN MAY 2021
Respiratory syncytial virus (RSV) is a common virus that infects the airways and lungs. It is highly contagious and spreads easily. RSV or respiratory syncytial virus can cause breathing problems and lung infections in children including bronchiolitis and pneumonia.
Older people and people who have problems with their heart, lungs or immune system are also at risk.
- Age: 18-75
- Sex: Males and females
- BMI: >/= 18-< = 40
- Medication: No inhaled or systemic corticosteroids
- Medical History: Up to 48 hours of upper respiratory tract infection (URTI) symptoms with at least one of the following symptoms: Nasal discharge, nasal congestion, malaise/tiredness, headache, sinus congestion, sneezing, sore throat, hoarseness, cough, shortness of breath, respiratory wheeze, earache, and/or symptoms of fever. Note: The duration of symptoms (not more than 48 hours) is to be measured from the estimated time of onset of the first symptom.
- Smoking History: Not exclusionary
- 5 visits over a 14 day period
- $59 per visit
How to apply
To register your interest in this trial, please complete this form. A Fusion team member will be in contact to discuss your eligibility shortly.